Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $27,633 | 916 | 96.9% |
| Travel and Lodging | $681.55 | 5 | 2.4% |
| Education | $151.12 | 19 | 0.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58.82 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,587 | 91 | $0 (2024) |
| Amarin Pharma Inc. | $3,147 | 64 | $0 (2022) |
| Amgen Inc. | $2,539 | 54 | $0 (2020) |
| PFIZER INC. | $2,432 | 110 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,394 | 67 | $0 (2024) |
| ABBVIE INC. | $1,514 | 43 | $0 (2024) |
| Novo Nordisk Inc | $1,348 | 73 | $0 (2024) |
| Radius Health, Inc. | $1,239 | 60 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,080 | 32 | $0 (2021) |
| Gilead Sciences, Inc. | $1,030 | 56 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $624.23 | 21 | Exact Sciences Corporation ($196.72) |
| 2023 | $632.20 | 28 | AbbVie Inc. ($175.13) |
| 2022 | $1,466 | 41 | Axonics, Inc. ($741.95) |
| 2021 | $1,383 | 57 | Boehringer Ingelheim Pharmaceuticals, Inc. ($257.85) |
| 2020 | $1,218 | 61 | PFIZER INC. ($247.89) |
| 2019 | $4,858 | 155 | Amarin Pharma Inc. ($822.93) |
| 2018 | $8,020 | 282 | Amarin Pharma Inc. ($1,207) |
| 2017 | $10,322 | 296 | AstraZeneca Pharmaceuticals LP ($1,526) |
All Payment Transactions
941 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Urology | ||||||
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes Care | ||||||
| 09/30/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $28.71 | General |
| Category: GI | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $122.50 | General |
| Category: Oncology | ||||||
| 08/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.07 | General |
| 07/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Respiratory | ||||||
| 05/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: DIABETES | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes Care | ||||||
| 04/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Respiratory | ||||||
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Respiratory | ||||||
| 02/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $74.22 | General |
| Category: Oncology | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Oncology | ||||||
| 08/11/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,644 | 11,831 | $1.1M | $651,165 |
| 2022 | 23 | 2,923 | 10,180 | $945,435 | $558,053 |
| 2021 | 27 | 3,056 | 9,606 | $860,709 | $485,883 |
| 2020 | 33 | 3,657 | 10,829 | $949,151 | $502,821 |
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 422 | 3,314 | $366,700 | $251,006 | 68.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 387 | 3,775 | $339,760 | $200,951 | 59.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 191 | 1,512 | $151,160 | $115,877 | 76.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $29,960 | $22,139 | 73.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 191 | 1,523 | $151,980 | $17,850 | 11.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 176 | 177 | $19,200 | $15,750 | 82.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 176 | 176 | $10,560 | $4,945 | 46.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 177 | 177 | $7,240 | $3,723 | 51.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 104 | $4,160 | $3,548 | 85.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 156 | 156 | $6,240 | $3,280 | 52.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 18 | 18 | $4,500 | $3,279 | 72.9% |
| 36410 | Insertion of needle into vein (3 years or older) | Office | 2023 | 139 | 222 | $4,440 | $3,172 | 71.4% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 103 | 105 | $6,300 | $2,148 | 34.1% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 23 | 23 | $2,530 | $1,234 | 48.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 57 | $2,850 | $711.84 | 25.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 67 | $1,005 | $637.84 | 63.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 41 | $630.00 | $344.40 | 54.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 53 | 86 | $516.00 | $276.06 | 53.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 46 | 55 | $275.00 | $187.55 | 68.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 26 | 88 | $1,070 | $105.84 | 9.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 482 | 3,123 | $360,275 | $239,258 | 66.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 394 | 3,328 | $299,540 | $172,620 | 57.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 187 | 878 | $87,800 | $64,577 | 73.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 159 | 159 | $30,920 | $22,980 | 74.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 185 | 185 | $20,120 | $16,565 | 82.3% |
About Dr. Robert Chan, MD
Dr. Robert Chan, MD is a Internal Medicine healthcare provider based in Alhambra, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508826488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Chan, MD has received a total of $28,525 in payments from pharmaceutical and medical device companies, with $624.23 received in 2024. These payments were reported across 941 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($27,633).
As a Medicare-enrolled provider, Chan has provided services to 12,280 Medicare beneficiaries, totaling 42,446 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Alhambra, CA
- Active Since 03/24/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508826488
Products in Payments
- Vascepa (Drug) $3,147
- FARXIGA (Drug) $1,857
- JARDIANCE (Drug) $1,829
- Tymlos (Biological) $1,210
- Prolia (Biological) $1,189
- ENTRESTO (Drug) $993.05
- ELIQUIS (Drug) $725.87
- Axonics (Device) $714.55
- CHANTIX (Drug) $710.64
- BRILINTA (Drug) $619.05
- Repatha (Biological) $601.09
- INVOKANA (Drug) $586.06
- TRADJENTA (Drug) $582.74
- Ozempic (Drug) $576.77
- LYRICA (Drug) $571.83
- BEVESPI AEROSPHERE (Drug) $565.31
- Victoza (Drug) $547.22
- LINZESS (Drug) $476.44
- Uloric (Drug) $448.10
- JANUVIA (Drug) $436.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Alhambra
Dr. Bosheng Qiu, M.d, M.D
Internal Medicine — Payments: $428,031
Henry Yee, Md, MD
Internal Medicine — Payments: $381,722
Dr. Nora Tee, M.d, M.D
Internal Medicine — Payments: $80,522
David Gu, D.o, D.O
Internal Medicine — Payments: $61,882
Jimmy Yue
Internal Medicine — Payments: $20,642
Jacqueline Wong, M.d, M.D
Internal Medicine — Payments: $18,500